4-((2,3-dihydro-2-(1H-inden-3-yl)-1-oxo-1H-inden-2-yl)-methyl)benzoic acid | 192194-37-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 4-((2,3-dihydro-2-(1H-inden-3-yl)-1-oxo-1H-inden-2-yl)-methyl)benzoic acid
• 英文别名: 4-[[2-(3H-inden-1-yl)-3-oxo-1H-inden-2-yl]methyl]benzoic acid
• CAS: 192194-37-9
• 化学式: C₂₆H₂₀O₃
• 分子量: 380.443
• InChiKey: HDWMNNXZILQHRD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  methyl 4-((2,3-dihydro-2-(1H-inden-3-yl)-1-oxo-1H-inden-2-yl)-methyl)benzoate 在 sodium hydroxide 、 盐酸 、 氯化铵 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 0.33h， 以69%的产率得到4-((2,3-dihydro-2-(1H-inden-3-yl)-1-oxo-1H-inden-2-yl)-methyl)benzoic acid
  参考文献：
  名称：

  A series of 1, 2-coupled indane dimers with mast cell stabilisation and smooth muscle relaxation properties

  摘要：

  Asthma is characterised by bronchoconstriction and inflammation, with infiltration and activation of inflammatory cells such as eosinophils and mast cells, and subsequent release of inflammatory mediators. Much of the therapy directed at the treatment of asthma is either to provide symptomatic relief through bronchodilation or to reduce inflammation to prevent or delay airway remodelling. in an attempt to address both of these issues, a novel series of 1,2-indane dimers has been synthesized and evaluated for smooth muscle relaxant and mast cell stabilising activities. We have identified two lead compounds, 5 and 15, which have substantial mast cell stabilisation activity. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.09.005

文献信息

• A series of 1, 2-coupled indane dimers with mast cell stabilisation and smooth muscle relaxation properties
  作者：H. Sheridan、J.J. Walsh、M. Jordan、C. Cogan、N. Frankish

  DOI：10.1016/j.ejmech.2009.09.005

  日期：2009.12

  Asthma is characterised by bronchoconstriction and inflammation, with infiltration and activation of inflammatory cells such as eosinophils and mast cells, and subsequent release of inflammatory mediators. Much of the therapy directed at the treatment of asthma is either to provide symptomatic relief through bronchodilation or to reduce inflammation to prevent or delay airway remodelling. in an attempt to address both of these issues, a novel series of 1,2-indane dimers has been synthesized and evaluated for smooth muscle relaxant and mast cell stabilising activities. We have identified two lead compounds, 5 and 15, which have substantial mast cell stabilisation activity. (C) 2009 Elsevier Masson SAS. All rights reserved.